Toyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice.

scientific article

Toyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice. is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2017PLoSO..1270591T
P356DOI10.1371/JOURNAL.PONE.0170591
P932PMC publication ID5344317
P698PubMed publication ID28278289

P50authorYusuke SakaiQ51719956
Susumu EguchiQ85201878
P2093author name stringKazuhiko Nakao
Masahiro Nakashima
Fuminao Takeshima
Ken Ohnita
Yuko Akazawa
Naota Taura
Katsuya Matsuda
Hisamitsu Miyaaki
Yasuko Kanda
Maiko Tabuchi
Ikuko Takahara
Youko Kido
P2860cites workXBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factorQ24292102
Identification of Toyocamycin, an agent cytotoxic for multiple myeloma cells, as a potent inhibitor of ER stress-induced XBP1 mRNA splicingQ24627782
Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1cQ28297047
Regulation of hepatic lipogenesis by the transcription factor XBP1Q28507784
XBP-1 Regulates a Subset of Endoplasmic Reticulum Resident Chaperone Genes in the Unfolded Protein ResponseQ28585314
An essential role in liver development for transcription factor XBP-1Q28593777
The natural history of nonalcoholic fatty liver disease: a population-based cohort studyQ29617161
ER stress triggers apoptosis by activating BH3-only protein BimQ29617730
Constitutive role for IRE1α-XBP1 signaling pathway in the insulin-mediated hepatic lipogenic programQ30426645
Hepatocytes release ceramide-enriched pro-inflammatory extracellular vesicles in an IRE1α-dependent mannerQ30701525
Saturated fatty acid induction of endoplasmic reticulum stress and apoptosis in human liver cells via the PERK/ATF4/CHOP signaling pathwayQ34128069
Bax inhibition protects against free fatty acid-induced lysosomal permeabilizationQ34665604
Vismodegib suppresses TRAIL-mediated liver injury in a mouse model of nonalcoholic steatohepatitis.Q34876724
ER stress and its regulator X-box-binding protein-1 enhance polyIC-induced innate immune response in dendritic cells.Q35168302
Dysregulation of the unfolded protein response in db/db mice with diet-induced steatohepatitisQ35490178
Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human conditionQ35562084
Death receptor 5 signaling promotes hepatocyte lipoapoptosisQ35604362
X-box binding protein 1 (XBP-1) enhances colorectal cancer cell invasion.Q53612351
ERβ decreases breast cancer cell survival by regulating the IRE1/XBP-1 pathway.Q54313198
Toll-like receptor-4 mediates obesity-induced non-alcoholic steatohepatitis through activation of X-box binding protein-1 in mice.Q54328614
Mechanisms underlying hypertriglyceridemia in rats with monosodium L-glutamate-induced obesity: evidence of XBP-1/PDI/MTP axis activation.Q54447692
A new biological role of sangivamycin; inhibition of protein kinasesQ69954354
Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitisQ73735584
Free fatty acids induce JNK-dependent hepatocyte lipoapoptosisQ82677113
Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitisQ36168809
Hepatocyte X-box binding protein 1 deficiency increases liver injury in mice fed a high-fat/sugar dietQ36382065
Hepatic Xbp1 Gene Deletion Promotes Endoplasmic Reticulum Stress-induced Liver Injury and ApoptosisQ36444262
Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver diseaseQ36820197
JNK1-dependent PUMA expression contributes to hepatocyte lipoapoptosisQ37446730
From sugar to fat: How the transcription factor XBP1 regulates hepatic lipogenesisQ37596560
Cdc42 and Rac1 are major contributors to the saturated fatty acid-stimulated JNK pathway in hepatocytesQ38594016
Mixed lineage kinase 3 deficient mice are protected against the high fat high carbohydrate diet-induced steatohepatitis.Q38627620
Glycogen synthase kinase-3 (GSK-3) inhibition attenuates hepatocyte lipoapoptosisQ39621569
Palmitoleate attenuates palmitate-induced Bim and PUMA up-regulation and hepatocyte lipoapoptosisQ39731721
Transcriptional regulation of Bim by FoxO3A mediates hepatocyte lipoapoptosisQ40108223
High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural studyQ41115222
The liver's dance with death: two Bcl-2 guardian proteins from the abyssQ42723851
Membrane lipid saturation activates IRE1α without inducing clusteringQ46157031
JNK1 but not JNK2 promotes the development of steatohepatitis in miceQ46865809
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectfatty acidQ61476
liver diseaseQ929737
steatosisQ1365091
metabolic dysfunction–associated steatotic liver diseaseQ1546498
fatty liver diseaseQ6058862
P304page(s)e0170591
P577publication date2017-03-09
P1433published inPLOS OneQ564954
P1476titleToyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice
P478volume12

Reverse relations

cites work (P2860)
Q45910813Artemisia iwayomogi plus Curcuma longa Synergistically Ameliorates Nonalcoholic Steatohepatitis in HepG2 Cells.
Q90351791Bitter melon extract ameliorates palmitate-induced apoptosis via inhibition of endoplasmic reticulum stress in HepG2 cells and high-fat/high-fructose-diet-induced fatty liver
Q92059471Calpain-2 activity promotes aberrant endoplasmic reticulum stress-related apoptosis in hepatocytes
Q59806057Chlorogenic acid against palmitic acid in endoplasmic reticulum stress-mediated apoptosis resulting in protective effect of primary rat hepatocytes
Q104073661Discovery of a novel fibroblast activation protein (FAP) inhibitor, BR103354, with anti-diabetic and anti-steatotic effects
Q33614924Effect of mild hypothermia preconditioning against low temperature (4°C) induced rat liver cell injury in vitro
Q52629172IRE1α-XBP1 inhibitors exerted anti-tumor activities in Ewing's sarcoma.
Q64069791Influences of sterol regulatory element binding protein-1c silencing on glucose production in HepG2 cells treated with free fatty acid
Q89940295Purple sweet potato color protects against hepatocyte apoptosis through Sirt1 activation in high-fat-diet-treated mice
Q54119547To die or not to die: death signaling in nonalcoholic fatty liver disease.

Search more.